Brokerages Set LivaNova PLC (NASDAQ:LIVN) PT at $61.17

Shares of LivaNova PLC (NASDAQ:LIVN) have earned an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $61.17.

Several research analysts have issued reports on LIVN shares. Stifel Nicolaus decreased their price target on shares of LivaNova from $72.00 to $60.00 and set a “buy” rating on the stock in a research report on Wednesday, February 26th. Needham & Company LLC reaffirmed a “buy” rating and set a $64.00 target price on shares of LivaNova in a report on Monday, March 17th. Mizuho cut their price objective on LivaNova from $70.00 to $60.00 and set an “outperform” rating on the stock in a report on Wednesday, February 26th. Barclays decreased their target price on shares of LivaNova from $58.00 to $56.00 and set an “equal weight” rating for the company in a report on Friday, March 7th. Finally, StockNews.com upgraded shares of LivaNova from a “buy” rating to a “strong-buy” rating in a report on Tuesday, March 25th.

Institutional Investors Weigh In On LivaNova

Hedge funds and other institutional investors have recently made changes to their positions in the company. Freestone Grove Partners LP acquired a new stake in LivaNova during the 4th quarter worth $23,102,000. Artisan Partners Limited Partnership bought a new stake in LivaNova in the fourth quarter valued at about $21,340,000. The Manufacturers Life Insurance Company lifted its stake in LivaNova by 163.6% in the fourth quarter. The Manufacturers Life Insurance Company now owns 546,387 shares of the company’s stock valued at $25,303,000 after buying an additional 339,139 shares during the period. AQR Capital Management LLC boosted its holdings in LivaNova by 79.3% during the fourth quarter. AQR Capital Management LLC now owns 742,180 shares of the company’s stock worth $34,214,000 after buying an additional 328,313 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of LivaNova by 12.7% in the 4th quarter. Vanguard Group Inc. now owns 2,349,887 shares of the company’s stock valued at $108,823,000 after acquiring an additional 265,291 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

LivaNova Trading Down 3.3 %

Shares of NASDAQ:LIVN opened at $35.10 on Friday. The company has a 50 day moving average of $37.76 and a 200-day moving average of $45.34. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. The firm has a market cap of $1.91 billion, a P/E ratio of 83.57 and a beta of 0.84. LivaNova has a twelve month low of $32.48 and a twelve month high of $64.07.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.